We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Mobile System Captures and Manages ECG Data

By HospiMedica International staff writers
Posted on 24 Jun 2015
Print article
Image: The InvisionHeart 12-lead ECG device (Photo courtesy of InvisionHeart).
Image: The InvisionHeart 12-lead ECG device (Photo courtesy of InvisionHeart).
A novel cloud-based healthcare IT platform enables physicians, nurses, and care providers to capture, review, and annotate patient 12-lead electrocardiogram (ECG) tracings.

The InvisionHeart ECG System is a mobile, cost-effective, technological solution for capturing and managing 12-lead ECGs, including the ability to read and visually compare, confirm, report, and store diagnostic quality readings. A proprietary high resolution 12-lead ECG device with an intuitive capture system is first used to record the ECG. The data is then transmitted to InvisionConnect, a secure cloud-based platform that allows a network of physicians, nurses, and technicians, to securely access and interpret patient the ECG readings.

Credentialed users can access ECGs from any web-enabled device, and additional cloud-based tools, such as messaging and notifications, help in the timely evaluation of patient ECGs. A web-based application with enhanced diagnostic tools assists in the review and formal diagnosis of patient ECGs, and integrates with electronic medical record systems (EMRs). The InvisionHeart ECG System is a product of InvisionHeart (Nashville, TN, USA), and has been approved by the US Food and Drug Administration (FDA).

“Initial interest has been strong from a broad array of potential users, especially those challenged to find a high-quality, low-cost solution that is secure and fully electronic,” said Melanie Varin, executive vice president of sales and marketing at InvisionHeart. “In addition to hospitals, we’ve detected genuine enthusiasm from the rapidly growing markets for home health and ambulatory care as well as other specialty markets.”

“This is a significant milestone in the development of our technology and, more importantly, a breakthrough in our ability to serve patients where ECGs have been traditionally unavailable,” said Josh Nickols, PhD, President and CEO of InvisionHeart. “Earlier diagnosis of cardiac issues via improved access will benefit patients, whether in the hospital setting or at home.”

In a conventional 12-lead ECG, electrodes are placed on the patient's limbs and on the surface of the chest. The overall magnitude of the heart's electrical potential is then measured from twelve different angles and is recorded over a period of time (usually 10 seconds). The heart's electrical depolarization is thus captured at each moment throughout the cardiac cycle, displayed as a graph representing of voltage versus time, i.e., the ECG.

Related Links:

InvisionHeart


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Radial Shock Wave Device
MASTERPULS »ultra«

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.